Skip to main content
Journal of Nanobiotechnology logoLink to Journal of Nanobiotechnology
. 2025 Mar 17;23:214. doi: 10.1186/s12951-025-03299-w

Correction: An antioxidant nanozyme for targeted cardiac fbrosis therapy post myocardial infarction

Ziyi Gu 1,#, Xueliang Liu 1,4,#, Zhen Qi 2, Zhou Fang 1, Yiting Jiang 1, Yuting Huang 1, Yongyi Wang 1,, Lianming Wu 3,, Yu Yang 1,
PMCID: PMC11912759  PMID: 40091045

Correction: Gu et al. Journal of Nanobiotechnology (2024) 22:760

10.1186/s12951-024-03047-6

In this article, affiliation 1 was incorrectly given as “Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Department of Cardiovascular Surgery, School of Medicine, Renji Hospital, Institute of Molecular Medicine (IMM), Shanghai Jiao Tong University, Shanghai, 200240, China”.

But should have been:

“Institute of Molecular Medicine (IMM), department of Cardiovascular Surgery, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China”.

The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s12951-024-03047-6.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Ziyi Gu and Xueliang Liu contributed equally to this work.

Contributor Information

Yongyi Wang, Email: yongyiwang77@163.com.

Lianming Wu, Email: wlmssmu@126.com.

Yu Yang, Email: yuyang@shsmu.edu.cn.


Articles from Journal of Nanobiotechnology are provided here courtesy of BMC

RESOURCES